Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IVF-M HP
- Development stage
- Phase 4
- Lead developer
- LG Chem
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Subcutaneous, Intramuscular
01
Overview
IVF-M HP is a highly purified preparation of human menopausal gonadotropin (hMG) developed by LG Chem. It is composed of human follicle-stimulating hormone (hFSH) and human luteinizing hormone (hLH) in a 1:1 ratio, extracted from the urine of postmenopausal women and refined to remove extraneous proteins. The drug acts as an agonist for both the follicle-stimulating hormone receptor (FSHR) and the luteinizing hormone/choriogonadotropin receptor (LHCGR). By stimulating these receptors on the ovarian granulosa and theca cells, IVF-M HP promotes the recruitment, development, and maturation of multiple ovarian follicles. It is primarily indicated for controlled ovarian hyperstimulation (COH) in women undergoing assisted reproductive technologies (ART), such as in vitro fertilization (IVF) and embryo transfer (IVF-ET).
- Brand names
- IVF-M HPIVF-M
- Other names
- human menopausal gonadotropinhMGHP-hMGmenotropinhighly purified human menopausal gonadotropin
02
Targets
FSHR (Follicle-stimulating hormone receptor)LHCGR (Luteinizing hormone/choriogonadotropin receptor)
Beyond the preview
Go deeper on IVF-M HP.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IVF-M HP.